Search Within

Andrew Briggs

Formats
  1. Journal Article (9)
  2. Meeting Abstract (5)
Groups
  1. Sloan Kettering Institute Postdocs (14)
  2. Surgery (5)
  3. CTCR Scholars (4)
  4. MSK Grad Students (4)
  5. Master of Science in Clinical and Translational Cancer Research (4)
  6. Melanoma Disease Management Team (4)

More Groups

People
  1. Daniel Coit (4)
  2. Edmund Bartlett (4)
  3. Yinin Hu (4)
  4. Charlotte Ariyan (3)
  5. Mary Brady (2)
  6. Michael Marchetti (2)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2019 (3)
  4. 2018 (5)
  5. 2017 (2)
  6. 2016 (1)
Publications
  1. Journal of the American College of Surgeons (3)
  2. Health Economics (2)
  3. PharmacoEconomics (2)
  4. Value in Health (2)
  5. Annals of Surgical Oncology (1)
  6. European Urology (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (7)
  2. Adis International Ltd. (2)
  3. John Wiley & Sons (2)
  4. Frontline Medical Communications (1)
  5. Project HOPE (1)
  6. Springer (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Moving beyond PSA: Identifying the optimal diagnostic strategy to assess prostate cancer risk
    Meeting Abstract

    Cheung, D.; Magee, D. E.; Stonier, T.; Briggs, A.; Ferket, B.; Finelli, A.; Kulkarni, G. S.; Vickers, A.; Carlsson, S.; Eastham, J.
    European Urology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy for T1b melanoma: Balancing prognostic value and cost
    Journal Article

    Hu, Y.; Briggs, A.; Gennarelli, R. L.; Bartlett, E. K.; Ariyan, C. E.; Coit, D. G.; Brady, M. S.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Cost-benefit implication of gene expression profiling and adjuvant therapy in stage IIIA melanoma
    Journal Article

    Hu, Y.; Briggs, A.; Marchetti, M. A.; Ariyan, C. E.; Coit, D. G.; Bartlett, E. K.
    Journal of the American College of Surgeons (2020)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy for T1b melanoma: Balancing prognostic value and cost
    Meeting Abstract

    Hu, Y.; Briggs, A.; Gennarelli, R.; Houghton, S.; Bartlett, E.; Ariyan, C.; Coit, D.; Brady, M. S.
    Journal of the American College of Surgeons (2019)

    Fulltext@MSK | Save
  • Cost-effectiveness of adjuvant therapy for stage IIIA melanoma is poor even when patients are risk-stratified by gene expression profile
    Meeting Abstract

    Hu, Y.; Briggs, A.; Marchetti, M.; Coit, D.; Bartlett, E.
    Journal of the American College of Surgeons (2019)

    Fulltext@MSK | Save
  • Estimating lifetime benefits associated with immuno-oncology therapies: Challenges and approaches for overall survival extrapolations
    Journal Article

    Ouwens, M. J. N. M.; Mukhopadhyay, P.; Zhang, Y.; Huang, M.; Latimer, N.; Briggs, A.
    PharmacoEconomics (2019)

    Fulltext@MSK | Save
  • Probabilistic sensitivity analysis in cost-effectiveness models: Determining model convergence in cohort models
    Journal Article

    Hatswell, A. J.; Bullement, A.; Briggs, A.; Paulden, M.; Stevenson, M. D.
    PharmacoEconomics (2018)

    Fulltext@MSK | Save
  • Prices for common cardiovascular drugs in the US are not consistently aligned with value
    Journal Article

    Campbell, J. D.; Belozeroff, V.; Whittington, M. D.; Rubin, R. J.; Raggi, P.; Briggs, A. H.
    Health Affairs (2018)

    Fulltext@MSK | Save
  • The impact of patient education on consideration of enrollment in clinical trials
    Journal Article

    Mancini, J.; Briggs, A.; Elkin, E. B.; Regan, J.; Hickey, C.; Targett, C.; Ager, R.; Masuda, S.; Bach, P. B.; Sabbatini, P. J.
    Journal of Community and Supportive Oncology (2018)

    Fulltext@MSK | Save
  • 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): An international, randomised, phase 3, non-inferiority trial
    Journal Article

    Iveson, T. J.; Kerr, R. S.; Saunders, M. P.; Cassidy, J.; Hollander, N. H.; Tabernero, J.; Haydon, A.; Glimelius, B.; Harkin, A.; Allan, K.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save